Department of Orthopedics, Massachusetts General Hospital, Boston, MA.
Center for Advanced Orthopedic Studies, Beth Israel Deaconess Medical Center, Boston, MA.
J Orthop Trauma. 2019 Jan;33(1):42-48. doi: 10.1097/BOT.0000000000001328.
This study is a systematic review and meta-analysis of the clinical outcomes and pooled complication rate of femoral, tibial, and humeral fracture fixation using SIGN nails. We aimed at comparing the pooled rate of adverse events based on the country of study origin, acute versus delayed fracture fixation, and length of follow-up.
We searched PubMed/MEDLINE/Cochrane databases from 2000 to 2016 for English language studies. There was substantial heterogeneity among included studies. Therefore, we used subgroup analysis of varying adverse events and removal of potential outlier studies based on the "remove one" sensitivity analysis to address the heterogeneity across studies. A funnel plot was drawn and inspected visually to assess publication bias. We reported pooled complication rates for each adverse event with 95% prediction interval.
There were 14 studies with 47,169 cases across 58 different low- and middle-income countries. The average age was 33 ± 14 years, with 83% men and 17% women. Sixty percent of SIGN nails used in these 14 studies were used in femur fracture fixation, 38% in tibial shaft fractures, and the remaining 2% for humeral shaft fractures. Approximately 23% of patients had follow-up data recorded. All studies that measured clinical outcome indicated that >90% achieved full weight-bearing status, favorable range of motion (knee range of motion >90 degrees according to the SIGN database), and radiographic or clinical union depending on the specific variable(s) measured in each study. The overall complication rate was 5.2% (4.4%-6.4%). Malalignment (>5 degrees of angulation in any plane) was the most common complication (7.6%), followed by delayed/nonunion (6.9%), infection (5.9%), and hardware failure, (3.2%).
Overall, the use of SIGN nails in fixing femoral, tibial, and humeral shaft fractures demonstrates good results with a high rate of return to full weight-bearing and radiographic/clinical union. The most common complications when using the SIGN nail are malalignment, delayed/nonunion, infection, and hardware failure.
Therapeutic Level IV. See Instructions for Authors for a complete description of levels of evidence.
本研究对 SIGN 钉治疗股骨、胫骨和肱骨骨折的临床结果和总体并发症发生率进行了系统评价和荟萃分析。我们旨在根据研究来源国、急性与延迟骨折固定以及随访时间的不同,比较不良事件的总体发生率。
我们检索了 2000 年至 2016 年期间的 PubMed/MEDLINE/Cochrane 数据库中的英文文献。纳入的研究之间存在很大的异质性。因此,我们使用了不同不良事件的亚组分析,并根据“逐个剔除”敏感性分析剔除潜在的离群研究,以解决研究之间的异质性。绘制漏斗图并进行视觉检查,以评估发表偏倚。我们报告了每个不良事件的汇总并发症发生率及其 95%预测区间。
共有 14 项研究纳入了来自 58 个不同中低收入国家的 47169 例患者。平均年龄为 33 ± 14 岁,男性占 83%,女性占 17%。这 14 项研究中,60%的 SIGN 钉用于股骨骨折固定,38%用于胫骨骨干骨折,其余 2%用于肱骨干骨折。大约 23%的患者有随访数据记录。所有测量临床结果的研究均表明,超过 90%的患者达到完全负重状态、良好的活动范围(根据 SIGN 数据库,膝关节活动范围>90 度)和影像学或临床愈合,具体取决于每项研究中测量的特定变量。总体并发症发生率为 5.2%(4.4%-6.4%)。最常见的并发症是对线不良(任何平面>5 度成角)(7.6%),其次是延迟/不愈合(6.9%)、感染(5.9%)和内固定物失效(3.2%)。
总体而言,SIGN 钉固定股骨、胫骨和肱骨骨干骨折的效果良好,患者能够快速恢复完全负重和影像学/临床愈合。使用 SIGN 钉时最常见的并发症是对线不良、延迟/不愈合、感染和内固定物失效。
治疗性 IV 级。欲了解完整的证据等级说明,请参见作者须知。